Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(13/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(13/week)
News
United States
(626/week)
Manufacturing
(450/week)
Energy
(343/week)
Technology
(477/week)
Other Manufacturing
(372/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Corticosteroids
Jun 12, 2020
Lilly and Dermira Present New Lebrikizumab Phase 2b Clinical Data Showing Patients with Atopic Dermatitis Had Clinically Meaningful Improvements in Itch, Sleep and Quality of Life
May 26, 2020
FDA Approves Dupixent® (dupilumab) as First Biologic Medicine for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis
May 07, 2020
Global Corticosteroids Therapy Industry & COVID-19, Forecast to 2030
Jan 29, 2020
Angie Seelal, R-PAC with Advanced Dermatology PC, Shares Tips on Managing Atopic Dermatitis
Apr 30, 2019
FDA approves trade name Lexette(TM) (halobetasol propionate) foam, 0.05%
Apr 05, 2019
Advisory - Multiple unauthorized health products sold at Sunrise Lee Chinese Herbs Centre in Calgary, Alberta, may pose serious health risks
Apr 04, 2019
Perrigo Announces Tentative FDA Approval For The Generic Version Of Sernivo® Spray, 0.05%
Feb 25, 2019
Bausch + Lomb Announces FDA Approval Of LOTEMAX® SM (loteprednol Etabonate Ophthalmic Gel) 0.38% For The Treatment Of Postoperative Inflammation And Pain Following Ocular Surgery
Feb 25, 2019
Positive Results Presented from Two Phase 3 Trials of Dupixent® (dupilumab) in Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Feb 13, 2019
Mayne Pharma launches Lexette (TM) (halobetasol propionate) foam 0.05% in the United States
Jan 15, 2019
Kamedis Receives Notice of Allowance for First US Patent on Botanical Eczema Treatment
Oct 31, 2018
Atopic Dermatitis Drugs Market Size Worth $6.41 Billion by 2022: Grand View Research, Inc.
Oct 26, 2018
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio
Oct 08, 2018
Bausch Health's BRYHALI(TM)(halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults
Oct 03, 2018
DS Biopharma Announces Positive Top-line Phase 2b Trial Results for Ds107 As a Topical Treatment for Mild to Moderate Atopic Dermatitis
Oct 02, 2018
Ortho Dermatologics Announces Publication Of Pivotal Phase 3 Efficacy And Safety Data On Bryhali(TM)* (Halobetasol Propionate) Lotion, 0.01% In The Journal Of Drugs In Dermatology
Sep 05, 2018
Bausch + Lomb Announces Publication Of Pivotal Phase 3 Data On Loteprednol Etabonate Ophthalmic Gel, 0.38% In Journal Of Cataract And Refractive Surgery
Jul 23, 2018
Dermtreat Announces First Patient Dosed in Phase 2b Clinical Trial of Rivelin Clobetasol for Oral Lichen Planus
Jul 11, 2018
Alimera Sciences Announces 8 ILUVIEN® Presentations At The 2018 American Society Of Retina Specialists Annual Meeting
Jun 13, 2018
Alcami's Extended Workbench Supports Commercial Supply of Flexion Therapeutics's ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)
Page 1
››
Latest News
May 7, 2024
Nidec Announces the Status of Own Share Repurchase
May 7, 2024
Kosmos Energy Announces First Quarter 2024 Results
May 7, 2024
Anaergia Announces Director Resignation That Had Been Anticipated in Pending Transaction
May 7, 2024
Trellix Receives Six Awards for Industry Leadership in Threat Detection and Response
May 7, 2024
92% of CISOs Question the Future of Their Role Amidst Growing AI Pressures
May 7, 2024
Trellix Database Security Safeguards Sensitive Data
May 7, 2024
Hayward Cuts Ribbon on Hayward Hub DFW
May 7, 2024
Otter Tail Corporation Announces First Quarter Earnings and Increases 2024 Annual Earnings Guidance
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events